Skip to main content

Table 4 Risk of bias assessment of RCT:

From: The effects of several postoperative adjuvant therapies for hepatocellular carcinoma patients with microvascular invasion after curative resection: a systematic review and meta-analysis

 

Random sequence generation

Allocation concealment

Blinding of participants and personnel

Blinding of outcome

Incomplete outcome data

Selective reporting

Other bias

Wei, 2018 [15]

Low risk

Unclear risk

Low risk

Low risk

Low risk

Low risk

Low risk

  1. RCT randomized clinical trial